Tacrolimus pharmacokinetics study in primary living donor liver transplantation patients with
Tacrolimus based immunosuppressive regimens.
Drug: FK506E (modified release tacrolimus)
Drug: Prograf (tacrolimus)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT00909571
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Patients receiving a primary partial liver graft from a living donor
Patients must receive the first dose of Tacrolimus after surgery and are expected to be maintained on Tacrolimus throughout the study
Patients receiving a multi-organ transplantation or having previously received an organ transplantation
Patients receiving an auxiliary graft or in whom a bio-artificial liver has been used
Patients allergic or intolerant to macrolide antibodies or Tacrolimus
All locations for NCT00909571
Korea, Republic of (1)
Seoul, Korea, Republic of
View full eligibility
Tris trial is registered with FDA with number: NCT00909571. The sponsor of the trial is Astellas Pharma Inc and it is looking for 10 volunteers for the current phase.
Official trial title: A Phase 3 Pilot Study to Describe the Pharmacokinetics of Tacrolimus in Patients Undergoing Primary Liver Donor Liver Transplantation Treated With Prograf Injection and Modified Release Tacrolimus Based Immunosuppressive Regimen
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!